Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium

NCT00003376 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

330

Enrollment

NETWORK

Sponsor class

Conditions

Bladder Cancer
Transitional Cell Cancer of the Renal Pelvis and Ureter
Urethral Cancer

Interventions

DRUG: carboplatin
DRUG: cisplatin
DRUG: doxorubicin hydrochloride
DRUG: methotrexate
DRUG: paclitaxel
DRUG: vinblastine

Sponsor

Eastern Cooperative Oncology Group

Collaborators

[object Object]
[object Object]